Comparison of in vitro dissolution profiles: Using a novel, model- independent approach

Pharmaceutical Technology

Volumn 24, Issue 3, 2000, Pages 92-102

  Gohel, Mukesh C ^a   Panchal, Maulik K ^a  

^a L M COLLEGE OF PHARMACY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DILTIAZEM;

ANALYTIC METHOD; ARTICLE; DRUG FORMULATION; DRUG SOLUBILITY; HUMAN; MATHEMATICAL MODEL; PHARMACEUTICAL ENGINEERING; SUSTAINED RELEASE PREPARATION;

EID: 0034061372     PISSN: 01478087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. W.A. Hanson and A.M. Paul, "Factors That Influence Dissolution Testing," in Pharmaceutical Dissolution Testing, U.V. Banakar, Ed. (Marcel Dekker, Inc., New York, 1992), pp. 133-183.
2. O. Andreas, "Process Validation of Oral Solid Dosage Forms - A Semiscientific Overview," Pharm. Technol. Eur. 9, 30-38 (1997).
3. S.A. Qureshi and I.J. McGilveray, "Assessment of Pharmaceutical Quality of Furosemide Tablets from Multinational Market," Drug Dev. Ind. Pharm. 24 (11), 995-1005 (1998).
4. J.E. Polli et al., "Methods to Compare Dissolution Profiles and a Rationale for Wide Dissolution Specification for Metoprolol Tartrate Tablets," J. Pharm. Sci. 86 (6), 690-700 (1997).
5. A. Rescigno, "Bioequivalence," Pharm. Res. 9 (7), 925-928 (1992).
6. J.W. Moore and H.H. Flanner, "Mathematical Comparison of Dissolution Profiles," Pharm. Technol. 20 (6), 64-74 (1996).
7. FDA, Center for Drug Evaluation and Research, "Guidance for Industry: Dissolution Testing of Immediate-Release Solid Oral Dosage Forms," August 1997.
8. P.M. Sathe, Y. Tsong, and V.P. Shah, "In Vitro Dissolution Profile Comparison: Statistics and Analysis, Model-Dependent Approach," Pharm. Res. 13 (12), 1799-1803 (1996).
9. Y. Tanigawara et al., "New Method for the Evaluation of In Vitro Dissolution Time and Disintegration Time," Chem. Pharm. Bull. 30, 1088-1090 (1982).
10. N.H. Anderson et al., "An Evaluation of Fit Factors and Dissolution Efficiency for the Comparison of In Vitro Dissolution Profiles," J. Pharm. Biomed. Anal. 17, 811-822 (1998).
11. K.A. Khan and C.T. Rhodes, "Effect of Compaction Pressure on the Dissolution Efficiency of Some Direct Compression Systems," Pharma. Acta Helv. 47, 594-607 (1972).
12. V. Pillay and R.J. Fassihi, "Evaluation and Comparison of Dissolution Data Derived from Different Modified-Release Dosage Forms: An Alternative Method," J. Control. Rel. 55 (1), 45-55 (1998).
13. M.C. Gohel and M.K. Panchal, "Formulation Optimization of Diltiazem HCl Matrix Tablets Containing Modified Guar Gum Using a Central Composite Design," Pharm. Pharmacol. Commun. 5 (5), 331-338 (1999).
14. M.A. Tanner, "Tools for Statistical Inference," in Lecture Notes in Statistics, Vol. 67 (Springer-Verlag, Berlin, 1992), noted in J. Pharm. Sci. 86 (6), 690-700 (1997).
15. M.A. Tanner, "Tools for Statistical Inference," in Lecture Notes in Statistics, Vol. 67 (Springer-Verlag, Berlin, 1992), noted in J. Pharm. Sci. 86 (6), 690-700 (1997).
16. W.D. Linder and B.C. Lippold, "Drug Release from Hydrocolloid Embedding with High or Low Susceptibility to Hydrodynamic Stress," Pharm. Res. 12 (11), 1781-1785 (1995).
17. FDA, Center for Drug Evaluation and Research, "Guidance for Industry: Immediate-Release Solid Oral Dosage Forms - Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls. In Vitro Dissolution Testing and In Vivo Bioequivalence Documentation," November 1995.
18. 2," Pharm. Res. 15 (6), 889-896 (1998).